Good morning:) Any friends Basal cell insitu lesion.I am on Eliquis. Does anyone have advice whetherMohs procedure...

Understanding Your Basal Cell Carcinoma Treatment Options

I can see you're navigating two important health considerations - a basal cell carcinoma in situ lesion and B-cell lymphoma, while also managing anticoagulation with Eliquis. Let me help you understand your treatment options.

---

1) Mohs Surgery vs. IG-SRT Radiation for Basal Cell Carcinoma

What You're Choosing Between:

Mohs Micrographic Surgery is a precise surgical technique where the surgeon removes thin layers of skin and examines them under a microscope during the procedure, continuing until all cancer cells are removed. It has the highest cure rate for basal cell carcinoma - typically 99% for first-time lesions.

IG-SRT (Image-Guided Superficial Radiation Therapy) is a non-invasive radiation treatment that delivers targeted doses to the skin cancer over multiple sessions (typically 15-20 treatments).

Key Considerations for YOUR Situation:

The Eliquis Factor: Since you're on Eliquis (apixaban), a blood thinner, this is an important consideration for Mohs surgery. According to dermatologic surgery guidelines, most patients can safely undergo Mohs surgery while continuing anticoagulation, though there's increased bleeding risk. Your dermatologist and prescribing physician should coordinate on whether to continue, pause, or bridge your Eliquis based on your stroke/clot risk versus bleeding risk.

The B-Cell Lymphoma Factor: This is particularly important. Having B-cell lymphoma means:

• Your immune system may already be compromised
• You may be receiving or may need immunosuppressive treatments
• Wound healing after surgery could be affected
• Your overall treatment burden matters

Comparing the Options:

Mohs Surgery Advantages:

• Highest cure rate (99% for primary basal cell)
• Tissue-sparing (removes minimal healthy skin)
• Immediate pathology confirmation
• Single-day procedure
• Gold standard for high-risk areas (face, ears, nose)

Mohs Surgery Considerations:

• Requires stopping or managing Eliquis
• Surgical wound requiring healing
• Potential complications if immune system compromised
• May need reconstructive closure

IG-SRT Advantages:

• No surgery required (no Eliquis management needed)
• No wound to heal
• No scarring from incisions
• May be preferable if you're immunocompromised
• Outpatient treatments over several weeks

IG-SRT Considerations:

• Slightly lower cure rates than Mohs (around 95%)
• Requires multiple visits (15-20 treatments)
• Radiation effects on skin (redness, irritation)
• Not ideal for all locations or deeper lesions
• Long-term cosmetic results may vary

Questions to Ask Your Dermatologist:

1. "What is the exact location and depth of my basal cell carcinoma? Is it truly in situ (confined to top layer)?"

   • Location and depth significantly influence treatment choice

2. "Given my B-cell lymphoma and current/planned treatments, which option poses less risk to my overall health?"

   • Coordinate with your oncologist on this

3. "What is your experience with IG-SRT versus Mohs for lesions like mine?"

   • Surgeon experience matters significantly

4. "How would we manage my Eliquis if I choose Mohs surgery? What are the bleeding risks?"

   • Get a clear anticoagulation management plan

5. "What are the recurrence rates for each option specifically for my lesion type and location?"

   • Personalize the statistics to your case

6. "If the basal cell recurs after IG-SRT, can I still have Mohs surgery later?"

   • Understand your backup options

---

2) Managing B-Cell Lymphoma Alongside Skin Cancer Treatment

The Intersection of Two Cancers:

Having both B-cell lymphoma and basal cell carcinoma requires coordinated care between your oncologist and dermatologist. According to the American Cancer Society, patients with blood cancers do have increased risk of skin cancers, partly due to immune system changes and sometimes due to treatments.

Important Coordination Points:

Treatment Timing:

• If you're currently on lymphoma treatment or planning to start soon, this affects healing and radiation tolerance
• Some lymphoma treatments can make skin more sensitive to radiation
• Immunosuppression from lymphoma treatment can affect surgical healing

Questions for Your Oncology Team:

1. "How does my current B-cell lymphoma status and treatment plan affect my skin cancer treatment options?"

2. "Are there any interactions between my lymphoma treatments and either Mohs surgery or radiation therapy?"

3. "Should we prioritize treating one condition before the other, or can they be managed simultaneously?"

4. "Does my lymphoma increase my risk of developing more skin cancers? Should I have more frequent skin checks?"

What I Don't Have Specific Research On:

I don't have specific guidelines in my knowledge base comparing Mohs versus IG-SRT specifically for patients with concurrent B-cell lymphoma on anticoagulation. This is a nuanced clinical scenario that requires individualized assessment by your care team.

---

🎯 My Recommendation for Next Steps:

1. Schedule a joint consultation or ensure your dermatologist and oncologist communicate directly about your case

2. Get clear answers on the Eliquis management plan for either treatment option

3. Understand your lymphoma treatment timeline and how it intersects with skin cancer treatment

4. Consider getting a second opinion from a dermatologic oncologist at a comprehensive cancer center where they regularly manage patients with multiple cancers

5. Ask about your specific cure rates - not just general statistics, but what success rates they see for patients in your situation

---

📚 Evidence Summary:

Strong Evidence Available:

• General Mohs surgery versus radiation therapy comparisons
• Anticoagulation management in dermatologic surgery
• Skin cancer risks in lymphoma patients

Limited Specific Evidence:

• Direct comparison of Mohs vs. IG-SRT in patients with concurrent B-cell lymphoma
• Optimal sequencing of treatments in your specific scenario

Specialist Consultation Recommended:

• Dermatologic oncologist for treatment selection
• Coordination between hematology/oncology and dermatology
• Possibly a multidisciplinary tumor board review

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions. Your unique situation with both cancers and anticoagulation requires individualized assessment that only your care team can provide after reviewing your complete medical history.

Would you like me to help you formulate specific questions to ask at your next appointments with either your dermatologist or oncologist?